Shah Amit B. 4
4 · Oncotelic Therapeutics, Inc. · Filed Jul 16, 2021
Insider Transaction Report
Form 4
Shah Amit B.
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Options
2021-07-08+698,256→ 698,256 totalExercise: $0.16From: 2021-07-08Exp: 2031-07-08→ Common Stock (698,256 underlying) - Award
Common Stock
2021-07-08+298,837→ 358,837 total
Footnotes (2)
- [F1]Shares were issued in settlement of Restricted Stock Units granted pursuant to the Issuer's 2015 Equity Incentive Plan that vested immediately upon grant.
- [F2]Stock options granted pursuant to the Issuer's 2015 Equity Incentive Plan, which vest immediately on date of grant.